Although α-MSH could be a biomarker for CFS within five years duration, the α-MSH level may be higher in other fatigue related diseases such as insomnia, sleep apnea and inflammatory diseases caused by virus infections. This evidence concerns the gene STAMBP and myalgic encephalomeyelitis/chronic fatigue syndrome.